OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Graeme Fielder

1 Projects | 1 Researchers | $2,417,356 Invested

2025

AviadoBio

Graeme Fielder, MBD, PhD

ASPIRE.FTD: A Phase 1/2 Open-Label, Ascending Dose, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of AVB-101 Administered by Bilateral Intrathalamic Infusion in Subjects With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)

  • Funding Amount: $2,417,356
  • Organization Type:
  • Program: Drug Discovery
  • Status: Active